IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases
NEW YORK & SOMERSET, N.J.--(BUSINESS WIRE)--IVERIC bio and Catalent entered into an agreement for production and manufacturing of AAV vector for IVERIC bio's gene therapy product candidates.